Review Article
Efficacy and Safety of Banxia Formulae for Insomnia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials
Table 1
Basic characteristics of the included studies.
| Included trials treatment | Publication language | No. of participants (male/female; age years) | Treatment | Outcome index | Duration | Intergroup difference | Experimental | Control | Experimental | Control |
| Chen 2019 [20] | Chinese | 25/15; 38.8 | 23/17; 38.6 | Huanglian wendan decoction | Tranquillizer | (1) Total effective rate | 20 d | (1) | (4) Adverse event(s) | (4) | Ding 2014 [21] | Chinese | 12/18; 62.5 | 13/17; 63.5 | Wendan decoction | Tranquillizer | (1) Total effective rate | 28 d | (1) | Fei 2018 [22] | Chinese | 8/18; 40.62 | 6/14; 41.05 | Chaihu wendan decoction | Estazolam | (1) Total effective rate | 4 w | (1) | (2) PSQI total score | (2) | (3) TCM syndrome score | (3) | (4) Adverse event(s) | (4) | Fu 2018 [23] | Chinese | 10/17; 57.33 | 8/18; 55.08 | Banxia Shumi decoction | Estazolam | (1) Total effective rate | 3 w | (1) | (2) PSQI total score | (2) | (3) TCM syndrome score | (3) | (4) Adverse event(s) | (4) | Guo 2016 [24] | Chinese | 17/13; 42.33 | 14/16; 40.43 | Banxia Shumi decoction | Zopiclone | (1) Total effective rate | 21 d | (1) | (2) PSQI total score | (2) | (3) TCM syndrome score | (3) | (4) Adverse event(s) | (4) | Huang 2013 [25] | Chinese | 15/5; 36.82 | 10/10; 41.16 | Wendan decoction | Tranquillizer | (1) Total effective rate | 20 d | (1) | (4) Adverse event(s) | (4) | Liu 2018 [26] | Chinese | 14/16; 52.43 | 13/17; 51.57 | Banxia Xiexin decoction | Alprazolam | (1) Total effective rate | 4 w | (1) | (2) PSQI total score | (2) | (4) Adverse event(s) | (4) | Wang 2012 [27] | Chinese | 34/28; 68.4 | 24/26; 69.6 | Huoxue Huayu Tongluo decoction | Estazolam | (1) Total effective rate | 30 d | (1) | Yin 2018 [28] | Chinese | 14/16; 24.74 | 14/16; 24.33 | Banxia Xiexin decoction | Estazolam | (1) Total effective rate | 21 d | (1) | (2) PSQI total score | (2) | (3) TCM syndrome score | (3) | Zhang 2012 [29] | Chinese | 21/39; 19–65 | 10/20; 18–63 | Banxia formula | Tranquillizer | (1) Total effective rate | 4 w | (1) | Zhang 2013 [30] | Chinese | 16/23; 23–65 | 17/24; 22–64 | Anshen Huatan decoction | Estazolam | (1) Total effective rate | 4 w | (1) | Zhang 2017 [31] | Chinese | 15/13; 59 | 12/12; 48 | Banxia Shumi decoction and Huanglian wendan decoction | Alprazolam | (1) Total effective rate | 2 w | (1) | (4) Adverse event(s) | (4) | Zhang 2019 [32] | Chinese | 8/21; 49.38 | 6/22; 44.21 | Banxia Xinxie decoction and Huanglian wendan decoction | Lorazepam | (1) Total effective rate | 4 w | (1) | (2) PSQI total score | (2) | (3) TCM syndrome score | (3) | (4) Adverse event(s) | (4) | Zheng 2016 [33] | Chinese | 9/21; 40.13 | 12/18; 38.25 | Banxia Shumi decoction | Tranquillizer | (1) Total effective rate | 7 d | (1) |
|
|
PSQI, Pittsburgh Sleep Quality Index.
|